What is HC Wainwright’s Estimate for CASI Q1 Earnings?
CASI Pharmaceuticals, Inc. (NASDAQ:CASI – Free Report) – Investment analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for shares of CASI Pharmaceuticals in a report released on Wednesday, April 9th. HC Wainwright analyst S. Lee forecasts that the biotechnology company will post earnings of ($0.61) per share for the quarter. […]
